ctDNA-based minimal residual disease detection in lung cancer patients treated with curative intended chemoradiotherapy using a clinically transferable approach

Background: Reliable biomarkers are needed to identify tumor recurrence of non-small cell lung cancer (NSCLC) patients after chemoradiotherapy (CRT) with curative intent. This could improve consolidation therapy of progressing patients. However, the approach of existing studies has limited transfera...

Description complète

Détails bibliographiques

Auteurs principaux:	Lærke Rosenlund Nielsen, Simone Stensgaard, Peter Meldgaard, Boe Sandahl Sorensen
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2024-01-01
Collection:	Cancer Treatment and Research Communications
Sujets:	NGS Biomarkers Liquid biopsies Time point Non-small cell lung cancer
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S2468294224000145
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!